Targeting long non-coding RNAs as new modulators in anti-EGFR resistance mechanisms
Epidermal growth factor receptor (EGFR) is a cell surface protein that plays a vital role in regulating cell growth and division. However, certain tumors, such as colorectal cancer (CRC), can exhibit an overexpression of EGFR, resulting in uncontrolled cell growth and tumor progression. To address t...
Main Authors: | Mostafa Akbarzadeh-Khiavi, Azam Safary, Yadollah Omidi |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2024-01-01
|
Series: | BioImpacts |
Subjects: | |
Online Access: | https://bi.tbzmed.ac.ir/PDF/bi-14-27696.pdf |
Similar Items
-
Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments
by: Yoojung Kwon, et al.
Published: (2019-09-01) -
Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles
by: Kim JS, et al.
Published: (2018-08-01) -
Long Noncoding RNA EGFR-AS1 Promotes Cell Proliferation by Increasing EGFR mRNA Stability in Gastric Cancer
by: Jiaojiao Hu, et al.
Published: (2018-08-01) -
Mechanisms of resistance to EGFR-targeted therapies in colorectal cancer: more than just genetics
by: Christine Parseghian, et al.
Published: (2023-09-01) -
Targeting Epidermal Growth Factor Receptor (EGFR) in Pediatric Colorectal Cancer
by: Maria Debora De Pasquale, et al.
Published: (2020-02-01)